Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects
about
Review: Breaking From Bisphosphonates.Bone-seeking agents for the treatment of bone disorders.Insights into the bisphosphonate holiday: a preliminary FTIRI study.Bortezomib prevents ovariectomy-induced osteoporosis in mice by inhibiting osteoclast differentiation.Histomorphometric and osteocytic characteristics of cortical bone in male subtrochanteric femoral shaft.Graphene-Based MicroRNA Transfection Blocks Preosteoclast Fusion to Increase Bone Formation and Vascularization.
P2860
Long-term safety of antiresorptive treatment: bone material, matrix and mineralization aspects
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Long-term safety of antiresorp ...... rix and mineralization aspects
@ast
Long-term safety of antiresorp ...... rix and mineralization aspects
@en
Long-term safety of antiresorp ...... rix and mineralization aspects
@nl
type
label
Long-term safety of antiresorp ...... rix and mineralization aspects
@ast
Long-term safety of antiresorp ...... rix and mineralization aspects
@en
Long-term safety of antiresorp ...... rix and mineralization aspects
@nl
prefLabel
Long-term safety of antiresorp ...... rix and mineralization aspects
@ast
Long-term safety of antiresorp ...... rix and mineralization aspects
@en
Long-term safety of antiresorp ...... rix and mineralization aspects
@nl
P2093
P2860
P356
P1433
P1476
Long-term safety of antiresorp ...... rix and mineralization aspects
@en
P2093
Barbara M Misof
Eleftherios P Paschalis
Klaus Klaushofer
Paul Roschger
P2860
P2888
P356
10.1038/BONEKEY.2015.1
P407
P577
2015-01-01T00:00:00Z
P5875
P6179
1000975396